BASEL, SWITZERLAND - Novartis will be cutting close to 2,000 jobs in the US, in New Jersey, as the result of an expected fall in demand for a relatively new medicine and the expiry of the patent for another, the company announced Friday 13 January in Basel. The sales force will lose 1,630 jobs and another 330 will go in related administrative posts. Staff will be informed of the specifics in April […]